Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Chronic Obstructive Pulmonary Disease: Micrornas and Exosomes As New Diagnostic and Therapeutic Biomarkers Publisher



Salimian J1 ; Mirzaei H1 ; Moridikia A1 ; Harchegani AB1 ; Sahebkar A2, 3 ; Salehi H4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Chemical Injuries Research Center, System Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
  2. 2. Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran
  3. 3. Department of Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
  4. 4. Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2018


Abstract

Chronic obstructive pulmonary disease (COPD) is known as a progressive lung disease and the fourth leading cause of death worldwide. Despite valuable efforts, there is still no accurate diagnostic and prognostic tool for COPD. Hence, it seems that finding new biomarkers could contribute to provide better therapeutic platforms for COPD patients. Among various biomarkers, microRNAs (miRNAs) have emerged as new biomarkers for the prognosis and diagnosis of patients with COPD. It has been shown that deregulation of miRNAs targeting a variety of cellular and molecular pathways such as Notch, Wnt, hypoxia-inducible factor-1α, transforming growth factor, Kras, and Smad could be involved in COPD pathogenesis. Multiple lines of evidence have indicated that extracellular vesicles such as exosomes could carry a variety of cargos (i.e., mRNAs, miRNAs, and proteins) which transfer various cellular and molecular signals to recipient cells. Here, we summarized various miRNAs which could be applied as diagnostic and prognostic biomarkers in the treatment of patients with COPD. Moreover, we highlighted the role of extracellular vesicles containing miRNAs as diagnostic and prognostic biomarkers in COPD patients. © 2018 Journal of Research in Medical Sciences.
Other Related Docs
12. Cervical Cancer Diagnosis: Insights Into Biochemical Biomarkers and Imaging Techniques, Combinatorial Chemistry and High Throughput Screening (2021)
17. Microrna: A Novel Target of Curcumin in Cancer Therapy, Journal of Cellular Physiology (2018)
19. Plasminogen Activator Inhibitor Type-1 As a Regulator of Fibrosis, Journal of Cellular Biochemistry (2018)
22. Therapeutic Application of Multipotent Stem Cells, Journal of Cellular Physiology (2018)
24. Green Tea and Its Anti-Angiogenesis Effects, Biomedicine and Pharmacotherapy (2017)
25. Microrna: Relevance to Stroke Diagnosis, Prognosis, and Therapy, Journal of Cellular Physiology (2018)
26. Molecular Imaging and Oral Cancer Diagnosis and Therapy, Journal of Cellular Biochemistry (2017)
32. Microrna Profiles in Critically Ill Patients, Current Medicinal Chemistry (2024)
35. Modulation of Micrornas by Aspirin in Cardiovascular Disease, Trends in Cardiovascular Medicine (2020)
36. Role of Micrornas in Pulmonary Hypertension, Horizons in World Cardiovascular Research (2022)
38. Micrornas As the Actors in the Atherosclerosis Scenario, Journal of Physiology and Biochemistry (2020)
50. A Review on Expression and Regulatory Mechanisms of Mir-337-3P in Cancer, Journal of Biomolecular Structure and Dynamics (2024)